🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is conducted in 3 stages. Stage 1 is an open-label, dose-escalat...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-01
Trial ID
NCT01397409
Treatments Being Tested
The purpose of this study is to investigate the safety, tolerability, bioac...
Status
Completed
Location
Retina Vitreous Associates
Start Date
2010-02
Trial ID
NCT01077401
Treatments Being Tested
This is a Phase III, multicenter, randomized, double-masked, dose-compariso...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00891735
Treatments Being Tested
This study is designed to compare the post injection inflammation and pain ...
Status
Completed
Location
Sierra Eye Associates
Start Date
2015-01
Trial ID
NCT02363621
Treatments Being Tested
The RAVE 2 trial is a phase I, open label, 12-month trial of intravitreal r...
Status
Terminated
Location
Retina Consultants of Houston
Start Date
2010-10
Trial ID
NCT01225146
Treatments Being Tested
A 2-year, phase 3, multicentre, randomised, parallel-group, sham-controlled...
Status
Terminated
Location
ShORe Investigational Site
Start Date
2021-03-12
Trial ID
NCT04757610
Treatments Being Tested
The purpose of this study is to determine whether ranibizumab (Lucentis) wi...
Status
Completed
Location
California Retina Consultants
Start Date
2010-01
Trial ID
NCT01028248
Treatments Being Tested
Pathologic myopia (PM) is characterized by progressive eye elongation assoc...
Status
Not Yet Recruiting
Location
Policlinico Rodolico
Start Date
2025-06-01
Trial ID
NCT07009574
Treatments Being Tested
ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) i...
Status
Active Not Recruiting
Location
Barnet Dulaney Eye Center-Phoenix /ID# 256340
Start Date
2022-01-13
Trial ID
NCT05407636
Treatments Being Tested
To assess the safety and efficacy of repeated intravitreal injections of DE...
Status
Completed
Location
Retina Research Institute
Start Date
2017-07-05
Trial ID
NCT03211234